ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,064 | -56.4% | 2,312,200 | 0.0% | 0.04% | -58.2% |
| Q2 2023 | $3,514,544 | -20.0% | 2,312,200 | 0.0% | 0.10% | -39.1% |
| Q1 2023 | $4,393,180 | +100.5% | 2,312,200 | 0.0% | 0.16% | +75.0% |
| Q4 2022 | $2,191,272 | -16.1% | 2,312,200 | 0.0% | 0.09% | -14.8% |
| Q3 2022 | $2,613,000 | -19.3% | 2,312,200 | 0.0% | 0.11% | -30.8% |
| Q2 2022 | $3,237,000 | -44.4% | 2,312,200 | +0.0% | 0.16% | -33.0% |
| Q1 2022 | $5,827,000 | -39.9% | 2,312,198 | +43.5% | 0.23% | -33.8% |
| Q4 2021 | $9,702,000 | -21.7% | 1,611,698 | +1.3% | 0.35% | -27.1% |
| Q3 2021 | $12,388,000 | -42.6% | 1,590,298 | +0.0% | 0.48% | -40.3% |
| Q2 2021 | $21,580,000 | – | 1,590,291 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,834,910 | $22,084,000 | 4.40% |
| venBio Partners LLC | 2,608,167 | $20,318,000 | 2.02% |
| Samsara BioCapital, LLC | 932,240 | $7,262,000 | 1.14% |
| Cormorant Asset Management, LP | 1,983,165 | $15,140,000 | 0.62% |
| BVF INC/IL | 1,590,298 | $12,388,000 | 0.48% |
| Boxer Capital, LLC | 1,341,530 | $10,451,000 | 0.36% |
| CAXTON CORP | 48,183 | $375,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,997,564 | $15,561,000 | 0.18% |
| Vivo Capital, LLC | 496,843 | $3,870,000 | 0.17% |
| CAAS CAPITAL MANAGEMENT LP | 60,000 | $467,000 | 0.01% |